🔎 Trials Near Me

Hjem › Ulcerøs colitis › Florida › Miami

Ulcerøs colitis kliniske forsøg i Miami, FL

21 studier for Ulcerøs colitis søger deltagere på steder i og omkring Miami (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • Research Associates of South Florida /ID# 280929, Miami
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • Gastro Health Research - Miami, Miami
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

RekruttererFase 3
  • Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585, Miami
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

RekruttererFase 2
  • ARA Professionals, Miami
Alder 16 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Well Pharma Medical Research Corp., Miami
  • Reserka, Miami
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RekruttererFase 2
  • 029, Miami
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

RekruttererFase 2
  • Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT07463183

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekruttererFase 2
  • Gastro Health Research - Miami, Miami
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07483073

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

RekruttererFase 2
  • Miami Clinical Research, Miami
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT07513181

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami
Alder 16 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07185009

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

RekruttererFase 1Frivillige med god helbredstilstand velkomne
  • Syneos Health Miami, Miami
Alder 18 til 55 · Alle køn · Opdateret 9. sep. 2026 · NCT07749768

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • Sanchez Clinical Research, Inc, Miami
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

RekruttererFase 2
  • University of Miami, Miami
  • Reliant Medical Research, Miami
Alder 18 til 80 · Alle køn · Opdateret 21. aug. 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • Columbus Clinical Services LLc - Site Number: 8400038, Miami
  • Regis Clinical Research, LLC - Site Number: 8400041, Miami
  • Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami - Site Number: 8400111, Miami
  • og 4 flere
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

RekruttererObservationsstudie
  • University of Miami, Miami
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07237516

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

RekruttererFase 1
  • AP Medical Research LLC, Miami
Alder 18 til 65 · Alle køn · Opdateret 12. jun. 2026 · NCT05666960

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Med-Care Research Corp, Miami
Alder 22 og opefter · Alle køn · Opdateret 28. apr. 2026 · NCT06810518

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

Rekrutterer
  • University of Miami Health System, Miami
Alder 16 til 75 · Alle køn · Opdateret 30. mar. 2026 · NCT06784323

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Rekrutterer
  • University of Miami Health, Miami
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852

Ulcerøs colitis forsøg i andre byer

Andre studier i Miami

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.